
Sign up to save your podcasts
Or


It doesn't seem to matter what bad news comes Facebook's way, the company just keeps chugging along. Its recent results show that users and revenue keep growing -- we break down earnings and talk about where future growth might come from.
Oh, and Apple reported earnings this week too. We chat about their new financial reporting structure and what's going on in its services segment.
Stocks: AAPL, FB
Check out more of our content here:
Motley Fool Contributor Lou Whiteman and IF host Nick Sciple round up all the latest news surrounding the defense industry. With the government shutdown on pause until February 15, defense contractors have had to adjust, and their most recent guidance suggests more uncertainty to come. However, the US military needs significant investment in its nuclear arsenal and missile defense is needed to bring them up to date. We discuss these issues and more on today's episode.
Stocks Mentioned:LMT, RTN, GD, NOC, BA, HRS, HII
Check out more of our content here:
Motley Fool Contributor Lou Whiteman and IF host Nick Sciple round up all the latest news surrounding the defense industry. With the government shutdown on pause until February 15, defense contractors have had to adjust, and their most recent guidance suggests more uncertainty to come. However, the US military needs significant investment in its nuclear arsenal and missile defense is needed to bring them up to date. We discuss these issues and more on today's episode.
Stocks Mentioned:LMT, RTN, GD, NOC, BA, HRS, HII
Check out more of our content here:
Biotech's biggest stories this year include trial data and FDA decisions for therapies targeting indications with a massive need for new treatment options, including blood disorders, genetic diseases, and Alzheimer's Disease. Here are six stocks that could pop or drop in 2019 based on these fast-approaching catalysts. Stocks: BIIB, BLUE, GBT, AIMT, DBVT, VRTX, SRPT
Check out more of our content here:
Biotech's biggest stories this year include trial data and FDA decisions for therapies targeting indications with a massive need for new treatment options, including blood disorders, genetic diseases, and Alzheimer's Disease. Here are six stocks that could pop or drop in 2019 based on these fast-approaching catalysts. Stocks: BIIB, BLUE, GBT, AIMT, DBVT, VRTX, SRPT
Check out more of our content here:
Starbucks (NASDAQ: SBUX) had a very strong quarter largely because it improved its execution and used its digital tools to drive sales. That’s CEO Kevin Johnson’s doing but the coffee chain boss also has scaled back plans to launch 1,000 Reserve Stores and adding Reserve bars to 20% of stores to a small pilot program. On this episode of Industry Focus: Consumer Goods, host Shannon Jones is joined by Fool.com contributor Daniel Kline to look into the company’s results and its efforts to drive traffic to afternoons and evenings.
Check out more of our content here:
Starbucks (NASDAQ: SBUX) had a very strong quarter largely because it improved its execution and used its digital tools to drive sales. That’s CEO Kevin Johnson’s doing but the coffee chain boss also has scaled back plans to launch 1,000 Reserve Stores and adding Reserve bars to 20% of stores to a small pilot program. On this episode of Industry Focus: Consumer Goods, host Shannon Jones is joined by Fool.com contributor Daniel Kline to look into the company’s results and its efforts to drive traffic to afternoons and evenings.
Check out more of our content here:
Synchrony Financial (NYSE: SYF) just got a big win, with two lingering issues resolved in the bank’s favor. And, Square (NYSE: SQ) recently rolled out yet another new product designed to strengthen its ecosystem even more. On this week’s episode of Industry Focus: Financials, host Jason Moser and Fool.com contributor Matt Frankel, CFP, give listeners the must-know details about these stories, answer some great listener emails, recap big bank earnings, and more.
Check out more of our content here:
Synchrony Financial (NYSE: SYF) just got a big win, with two lingering issues resolved in the bank’s favor. And, Square (NYSE: SQ) recently rolled out yet another new product designed to strengthen its ecosystem even more. On this week’s episode of Industry Focus: Financials, host Jason Moser and Fool.com contributor Matt Frankel, CFP, give listeners the must-know details about these stories, answer some great listener emails, recap big bank earnings, and more.
Check out more of our content here:
The modem company has been using a "no license, no chips" policy for the longest time to dominate the smartphone supplier market. But with the company battling the FTC, that power dynamic could swiftly change. If Qualcomm is forced to change its business model, how will that affect the company's financials?
Stocks: QCOM, AAPL
Check out more of our content here:
Thanks to Molekule for supporting our channel. Get $75 off your first order at http://www.molekule.com code fool75.
From the publisher's feed

3,160 Listeners

807 Listeners

934 Listeners

1,604 Listeners